MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TECX had $113,044K increase in cash & cash equivalents over the period. -$60,286K in free cash flow.

Cash Flow Overview

Change in Cash
$113,044K
Free Cash flow
-$60,286K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from the private placem...
    • Stock-based compensation expense
    • Prepaid expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Operating lease liabilities
    • Accrued expenses and other curre...
    • Others

Cash Flow
2025-12-31
Net loss
-74,151
Depreciation and amortization expense
1,375
Stock-based compensation expense
10,497
Loss on sale of property and equipment
-153
Reduction in the carrying amount of the operating right-of-use assets
2,118
Change in fair value of safe liabilities
0
Prepaid expenses and other current assets
-2,644
Othernon-currentassets
-17
Accounts payable
116
Accrued expenses and other current liabilities
-552
Operating lease liabilities
-2,295
Net cash used in operating activities
-60,078
Purchase of property and equipment
208
Proceeds from the sale of property and equipment
70
Net cash used in investing activities
-138
Proceeds from the private placement, net of offering costs of 11,928
173,098
Proceeds from the subscription agreement, net of offering costs of 2,000
0
Cash acquired in connection with the merger, net of transaction costs of 7,412
0
Proceeds from exercise of stock options
1,231
Payments for employee taxes related to net share settlement of equity awards
17
Payment of deferred offering costs
-468
Repayment of finance lease obligations
489
Net cash provided by financing activities
173,355
Effect of exchange rate changes on cash and cash equivalents
-95
Net increase in cash and cash equivalents and restricted cash
113,044
Cash and cash equivalents and restricted cash as of beginning of period
141,826
Cash and cash equivalents and restricted cash as of end of period
254,870
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from the privateplacement, net of offering...$173,098K Proceeds from exercise ofstock options$1,231K Net cash provided byfinancing activities$173,355K Canceled cashflow$974K Net increase in cashand cash...$113,044K Canceled cashflow$60,311K Repayment of finance leaseobligations$489K Payment of deferredoffering costs-$468K Payments for employeetaxes related to net...$17K Stock-based compensationexpense$10,497K Prepaid expenses andother current assets-$2,644K Reduction in the carryingamount of the operating...$2,118K Depreciation andamortization expense$1,375K Loss on sale ofproperty and equipment-$153K Accounts payable$116K Othernon-currentassets-$17K Proceeds from the sale ofproperty and equipment$70K Net cash used inoperating activities-$60,078K Net cash used ininvesting activities-$138K Effect of exchange ratechanges on cash and cash...-$95K Canceled cashflow$16,920K Canceled cashflow$70K Net loss-$74,151K Purchase of property andequipment$208K Operating leaseliabilities-$2,295K Accrued expenses andother current...-$552K

Tectonic Therapeutic, Inc. (TECX)

Tectonic Therapeutic, Inc. (TECX)